These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1666559)

  • 1. Control of coronary vasomotor tone in ischaemic myocardium by local metabolism and neurohumoral mechanisms.
    Heusch G
    Eur Heart J; 1991 Dec; 12 Suppl F():99-106. PubMed ID: 1666559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local and neurohumoral control of coronary blood flow.
    Krajcar M; Heusch G
    Basic Res Cardiol; 1993; 88 Suppl 1():25-42. PubMed ID: 8395171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sympathetic nervous system and ischaemic heart disease.
    Remme WJ
    Eur Heart J; 1998 Jun; 19 Suppl F():F62-71. PubMed ID: 9651738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of coronary blood flow during exercise.
    Duncker DJ; Bache RJ
    Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurogenic regulation of coronary vasomotor tone.
    Heusch G; Guth BD
    Eur Heart J; 1989 Nov; 10 Suppl F():6-14. PubMed ID: 2695336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuronal control of coronary blood flow.
    Baumgart D; Heusch G
    Basic Res Cardiol; 1995; 90(2):142-59. PubMed ID: 7646417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of vasomotor tone to myocardial function and regional metabolism during constant flow ischaemia in swine.
    McFalls EO; Pantely GA; Anselone CG; Bristow DJ
    Cardiovasc Res; 1990 Oct; 24(10):813-20. PubMed ID: 2085836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Coronary vasomotion in myocardial ischemia].
    Heusch G
    Z Kardiol; 1989 Aug; 78(8):485-99. PubMed ID: 2678793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of the sympathetic nervous system for the coronary circulation].
    Heusch G; Thämer V
    Z Kardiol; 1984 Sep; 73(9):543-51. PubMed ID: 6506839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydropyridine calcium antagonists: beneficial or adverse effects in the setting of myocardial ischaemia/reperfusion?
    Ehring T; Heusch G
    Cardiology; 1997; 88 Suppl 1():3-14; discussion 15-6. PubMed ID: 9118166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of neuropeptide Y on coronary artery vasomotion in patients with microvascular angina.
    Rosano GMC; Tousoulis D; McFadden E; Clarke J; Davies GJ; Kaski JC
    Int J Cardiol; 2017 Jul; 238():123-127. PubMed ID: 28476516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-ischaemic effects of converting enzyme inhibitors: underlying mechanisms and future prospects.
    Remme WJ; Bartels GL
    Eur Heart J; 1995 Aug; 16 Suppl I():87-95. PubMed ID: 8829963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of alpha-adrenergic coronary constriction by calcium-antagonists.
    Heusch G; Deussen A; Guth BD
    Basic Res Cardiol; 1990; 85 Suppl 1():219-28. PubMed ID: 1965399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary artery vasomotion and post-stenotic coronary artery blood flow after intracoronary lacidipine in patients with ischaemic heart disease: a pilot study.
    Vassanelli C; Menegatti G; Marini A; Beltrame F; Molinari J; Cemin R
    Drugs; 1999; 57 Suppl 1():19-26. PubMed ID: 10529079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary-artery spasm.
    Hillis LD; Braunwald E
    N Engl J Med; 1978 Sep; 299(13):695-702. PubMed ID: 210380
    [No Abstract]   [Full Text] [Related]  

  • 16. Coronary arteriolar vasoconstriction in myocardial ischaemia: coronary vasodilator reserve during ischaemia.
    Bache RJ; Laxson DD
    Eur Heart J; 1990 Apr; 11 Suppl B():5-9. PubMed ID: 1973099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tonus of epicardial main arteries and dynamic stenosis].
    Bassenge E
    Z Kardiol; 1984; 73 Suppl 2():55-61. PubMed ID: 6528704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute effects of angiotensin-converting enzyme inhibition on coronary vasomotion in hypertensive patients.
    Nitenberg A; Antony I
    Eur Heart J; 1998 Sep; 19 Suppl J():J45-51. PubMed ID: 9796840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of converting enzyme inhibitors on coronary flow and myocardial ischemia.
    van Gilst WH; Tio RA; van Wijngaarden J; de Graeff PA; Wesseling H
    J Cardiovasc Pharmacol; 1992; 19 Suppl 5():S134-9. PubMed ID: 1381790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local metabolic hypothesis is not sufficient to explain coronary autoregulatory behavior.
    Kiel AM; Goodwill AG; Baker HE; Dick GM; Tune JD
    Basic Res Cardiol; 2018 Aug; 113(5):33. PubMed ID: 30073416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.